Latest Insider Transactions at Option Care Health, Inc. (OPCH)
This section provides a real-time view of insider transactions for Option Care Health, Inc. (OPCH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Option Care Health, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Option Care Health, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 10
2021
|
Timothy P Sullivan Director |
SELL
Open market or private sale
|
Indirect |
17,250,000
-20.29%
|
$345,000,000
$20.0 P/Share
|
Jun 10
2021
|
Madison Dearborn Partners LLC |
SELL
Open market or private sale
|
Indirect |
17,250,000
-20.27%
|
$345,000,000
$20.0 P/Share
|
Jun 10
2021
|
Elizabeth Quadros Betten Director |
SELL
Open market or private sale
|
Indirect |
17,250,000
-20.29%
|
$345,000,000
$20.0 P/Share
|
May 26
2021
|
R Carter Pate Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,626
+11.85%
|
-
|
May 26
2021
|
David W Golding Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,428
+13.75%
|
-
|
May 26
2021
|
Elizabeth Quadros Betten Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,841
+23.79%
|
-
|
May 26
2021
|
Harry M Jansen Kraemer Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,650
+14.22%
|
-
|
May 26
2021
|
John Arlotta Director |
BUY
Grant, award, or other acquisition
|
Indirect |
13,851
+23.66%
|
-
|
May 26
2021
|
Nitin Sahney Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,626
+23.55%
|
-
|
May 26
2021
|
Timothy P Sullivan Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,559
+23.56%
|
-
|
May 19
2021
|
Harry M Jansen Kraemer Jr Director |
BUY
Open market or private purchase
|
Direct |
40,000
+32.32%
|
$680,000
$17.59 P/Share
|
May 11
2021
|
Michael H. Shapiro Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
2,500
+50.0%
|
$40,000
$16.33 P/Share
|
May 11
2021
|
John Charles Rademacher Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
$160,000
$16.42 P/Share
|
May 10
2021
|
R Carter Pate Director |
BUY
Open market or private purchase
|
Direct |
855
+0.96%
|
$13,680
$16.74 P/Share
|
Mar 17
2021
|
Elizabeth Quadros Betten Director |
SELL
Open market or private sale
|
Indirect |
12,000,000
-12.37%
|
$240,000,000
$20.0 P/Share
|
Mar 17
2021
|
Madison Dearborn Partners LLC |
SELL
Open market or private sale
|
Indirect |
12,000,000
-12.36%
|
$240,000,000
$20.0 P/Share
|
Mar 17
2021
|
Timothy P Sullivan Director |
SELL
Open market or private sale
|
Indirect |
12,000,000
-12.37%
|
$240,000,000
$20.0 P/Share
|
Feb 23
2021
|
John Charles Rademacher Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
52,716
+45.67%
|
-
|
Feb 23
2021
|
Michael H. Shapiro Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,816
+46.34%
|
-
|
Feb 23
2021
|
Clifford E Berman Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,272
+50.0%
|
-
|
Feb 23
2021
|
Robert R Kampstra CHIEF ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
2,504
+50.0%
|
-
|
Feb 23
2021
|
Harriet Booker CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
18,452
+6.75%
|
-
|
Feb 23
2021
|
Richard Denness Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,888
+9.68%
|
-
|
Feb 10
2021
|
Timothy P Sullivan Director |
SELL
Open market or private sale
|
Indirect |
17,250,000
-15.1%
|
$310,500,000
$18.5 P/Share
|
Feb 10
2021
|
Elizabeth Quadros Betten Director |
SELL
Open market or private sale
|
Indirect |
17,250,000
-15.1%
|
$310,500,000
$18.5 P/Share
|
Dec 29
2020
|
Elizabeth Quadros Betten Director |
SELL
Open market or private sale
|
Indirect |
600,000
-0.52%
|
$9,000,000
$15.0 P/Share
|
Dec 29
2020
|
Timothy P Sullivan Director |
SELL
Open market or private sale
|
Indirect |
600,000
-0.52%
|
$9,000,000
$15.0 P/Share
|
Dec 29
2020
|
Madison Dearborn Partners LLC |
SELL
Open market or private sale
|
Indirect |
600,000
-0.52%
|
$9,000,000
$15.0 P/Share
|
Dec 24
2020
|
Elizabeth Quadros Betten Director |
SELL
Other acquisition or disposition
|
Indirect |
7,048,357
-5.78%
|
-
|
Dec 24
2020
|
Timothy P Sullivan Director |
SELL
Other acquisition or disposition
|
Indirect |
7,048,357
-5.78%
|
-
|
Dec 24
2020
|
Madison Dearborn Partners LLC |
SELL
Other acquisition or disposition
|
Indirect |
7,048,357
-5.78%
|
-
|
Dec 14
2020
|
Madison Dearborn Partners LLC |
SELL
Open market or private sale
|
Indirect |
10,000,000
-7.58%
|
$150,000,000
$15.0 P/Share
|
Dec 14
2020
|
Timothy P Sullivan Director |
SELL
Open market or private sale
|
Indirect |
10,000,000
-7.58%
|
$150,000,000
$15.0 P/Share
|
Dec 14
2020
|
Elizabeth Quadros Betten Director |
SELL
Open market or private sale
|
Indirect |
10,000,000
-7.58%
|
$150,000,000
$15.0 P/Share
|
Dec 10
2020
|
Madison Dearborn Partners LLC |
SELL
Open market or private sale
|
Indirect |
17,250,000
-15.09%
|
$310,500,000
$18.5 P/Share
|
Aug 06
2020
|
Richard Denness Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,709
-9.33%
|
$80,508
$12.16 P/Share
|
Aug 06
2020
|
Richard Denness Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,187
+22.76%
|
-
|
Aug 01
2020
|
Richard Denness Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,352
-2.6%
|
$14,872
$11.78 P/Share
|
Aug 01
2020
|
Richard Denness Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,735
+8.33%
|
-
|
Mar 09
2020
|
Harriet Booker CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
29,988
+11.26%
|
-
|
Mar 09
2020
|
Richard Denness Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,492
+21.45%
|
-
|
Aug 06
2019
|
Coliseum Capital Management, LLC |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
18,905
-0.54%
|
$37,810
$2.67 P/Share
|
Aug 06
2019
|
Coliseum Capital Management, LLC |
BUY
Exercise of conversion of derivative security
|
Indirect |
18,905
+0.54%
|
-
|
Aug 06
2019
|
Coliseum Capital Management, LLC |
BUY
Grant, award, or other acquisition
|
Indirect |
1,576,621
+16.15%
|
-
|
Jun 10
2019
|
Coliseum Capital Management, LLC |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
43,726
-2.26%
|
$87,452
$2.19 P/Share
|
Jun 10
2019
|
Coliseum Capital Management, LLC |
BUY
Exercise of conversion of derivative security
|
Indirect |
43,726
+2.21%
|
-
|
May 02
2018
|
Coliseum Capital Management, LLC |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
49,669
-2.56%
|
$99,338
$2.69 P/Share
|
May 02
2018
|
Coliseum Capital Management, LLC |
BUY
Exercise of conversion of derivative security
|
Indirect |
49,669
+2.5%
|
-
|
Sep 07
2017
|
Coliseum Capital Management, LLC |
SELL
Open market or private sale
|
Indirect |
1,275,637
-40.31%
|
$2,551,274
$2.88 P/Share
|
Sep 06
2017
|
Coliseum Capital Management, LLC |
SELL
Open market or private sale
|
Indirect |
1,349,475
-29.89%
|
$2,698,950
$2.96 P/Share
|